JP2025514278A5 - - Google Patents

Info

Publication number
JP2025514278A5
JP2025514278A5 JP2024563506A JP2024563506A JP2025514278A5 JP 2025514278 A5 JP2025514278 A5 JP 2025514278A5 JP 2024563506 A JP2024563506 A JP 2024563506A JP 2024563506 A JP2024563506 A JP 2024563506A JP 2025514278 A5 JP2025514278 A5 JP 2025514278A5
Authority
JP
Japan
Prior art keywords
modified bont
bont
wrinkles
administered
modified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024563506A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025514278A (ja
Filing date
Publication date
Priority claimed from GBGB2206362.2A external-priority patent/GB202206362D0/en
Application filed filed Critical
Publication of JP2025514278A publication Critical patent/JP2025514278A/ja
Publication of JP2025514278A5 publication Critical patent/JP2025514278A5/ja
Pending legal-status Critical Current

Links

JP2024563506A 2022-04-29 2023-04-28 上部顔面の皺線の処置 Pending JP2025514278A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB2206362.2A GB202206362D0 (en) 2022-04-29 2022-04-29 Treatment of upper facial lines
GB2206362.2 2022-04-29
PCT/GB2023/051152 WO2023209403A1 (en) 2022-04-29 2023-04-28 Treatment of upper facial lines

Publications (2)

Publication Number Publication Date
JP2025514278A JP2025514278A (ja) 2025-05-02
JP2025514278A5 true JP2025514278A5 (enExample) 2026-05-08

Family

ID=81943827

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024563506A Pending JP2025514278A (ja) 2022-04-29 2023-04-28 上部顔面の皺線の処置

Country Status (9)

Country Link
US (1) US20250177278A1 (enExample)
EP (1) EP4514314A1 (enExample)
JP (1) JP2025514278A (enExample)
KR (1) KR20250005398A (enExample)
CN (1) CN119095579A (enExample)
AU (1) AU2023259716A1 (enExample)
CA (1) CA3245916A1 (enExample)
GB (1) GB202206362D0 (enExample)
WO (1) WO2023209403A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025093845A1 (en) * 2023-11-01 2025-05-08 Ipsen Biopharm Limited Use of high dose chimeric botulinum toxin a for the treatment of upper facial lines

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
IL99552A0 (en) 1990-09-28 1992-08-18 Ixsys Inc Compositions containing procaryotic cells,a kit for the preparation of vectors useful for the coexpression of two or more dna sequences and methods for the use thereof
DE102004043009A1 (de) 2004-09-06 2006-03-23 Toxogen Gmbh Transportprotein zum Einbringen chemischer Verbindungen in Nervenzellen
DE102005019302A1 (de) 2005-04-26 2006-11-16 Toxogen Gmbh Carrier zum Targeting von Nervenzellen
DK2154151T3 (da) 2005-09-19 2011-09-05 Allergan Inc Clostridiumtoksinaktiverbare clostridiumtoksiner
WO2010120766A1 (en) 2009-04-14 2010-10-21 Mcw Research Foundation, Inc. Engineered botulinum neurotoxin
US8853360B2 (en) 2010-06-23 2014-10-07 Wisconsin Alumni Research Foundation Engineered botulinum neurotoxin C1 with selective substrate specificity
EP2524963B1 (en) 2011-05-19 2018-10-31 Ipsen Bioinnovation Limited Methods for the manufacture of proteolytically processed polypeptides
MX359480B (es) 2012-05-30 2018-09-28 President And Fellows Of Harvard College Star Neurotoxina botulínica diseñada.
JP6156954B2 (ja) 2012-11-21 2017-07-05 イプセン バイオイノベーション リミテッド タンパク分解性にプロセシングされたポリペプチドの製造方法
RU2746736C2 (ru) 2015-03-26 2021-04-20 Президент Энд Феллоуз Оф Гарвард Колледж Сконструированный ботулинический нейротоксин
GB201607901D0 (en) 2016-05-05 2016-06-22 Ipsen Biopharm Ltd Chimeric neurotoxins
EP3481852B1 (en) 2016-07-08 2022-12-07 Children's Medical Center Corporation A novel botulinum neurotoxin and its derivatives
CA3057302A1 (en) * 2017-03-22 2018-09-27 Bonti, Inc. Botulinum neurotoxin serotype e for use in cosmetic treatment
GB202003813D0 (en) * 2020-03-16 2020-04-29 Ipsen Biopharm Ltd Treatment of upper facial lines

Similar Documents

Publication Publication Date Title
JP2023517727A5 (enExample)
JP2020045360A5 (enExample)
US20240238393A1 (en) Composition comprising botulinum toxin
Carruthers et al. Clinical indications and injection technique for the cosmetic use of botulinum A exotoxin
Başar et al. Use of botulinum neurotoxin in ophthalmology
Bulstrode et al. Long-term prospective follow-up of botulinum toxin treatment for facial rhytides
BR112022018457A2 (pt) Tratamento de linhas faciais superiores
JP2023529095A5 (enExample)
US20230329996A1 (en) High dose and low volume botulinum toxin treatment of facial wrinkles
Campanati et al. Plantar focal idiopathic hyperhidrosis and botulinum toxin: a pilot study
Feily et al. A succinct review of botulinum toxin in dermatology; update of cosmetic and noncosmetic use
Morgado-Carrasco et al. [Translated article] Topical anticholinergics in the management of focal hyperhidrosis in adults and children. A narrative review
TW202435908A (zh) 組成物及應用其之注射裝置
JP2025515346A5 (enExample)
RU2024129879A (ru) Лечение морщин верхней части лица
JP2011157331A (ja) 高用量投与が可能なボツリヌス毒素製剤
KR101824450B1 (ko) 히알루로니다제를 포함한 지방분해 및 보톡스 기능이 강화된 약물 키트
JP2024543080A (ja) ボツリヌス毒素組成物
Antonio et al. Botulinum toxin: a review of its applicability in diseases within the reach of dermatologists
Büyükafşar Pharmacology of botulinum toxins: From poison to remedy
RU2835617C1 (ru) Лечение морщин на лице высокой дозой и малым объемом ботулинического токсина
KR102790255B1 (ko) 재조합 보툴리눔 독소 및 이를 함유하는 약학 조성물
Abbas et al. www. cosmoderma. org
Lapa et al. Botulinum toxin for the head and neck: a review of common uses and recent trends
Anna et al. 22 for the Upper Face